It’s no secret that 2025 is turning into a tricky year for life science companies looking to raise cash. Political and economic uncertainty has fed through into a ‘risk-off’ environment. So, when DeepMind spin-out Isomorphic Labs, a London-based AI drug development company, announced last week (March 31) that it had pocketed a huge $600 million […]
Back in mid-January Optimum’s Hot Topics column took a look at life expectancy data and asked the rather depressing question: “Will you live longer than your parents – or not?” Why so downbeat? Because besides stalling life expectancy figures, a slew of other data also seemed to hint that longevity might have peaked: steadily growing […]
The catastrophic fall from grace of the genetic testing app 23 and Me is a salutary lesson for all companies that espouse the use of “big data” in healthcare. Once a leading digital health tech firm, worth $6 billion as recently as 2021, the company is now on the verge of being taken private at […]
What debilitating condition affects 1.5 million women in the UK, and yet takes almost nine years on average to be diagnosed? A condition that – despite the numbers it affects – is so poorly recognised that it is often mistaken for something else, or written off as unimportant? That results in pain so bad it […]
For this year’s International Day of Women and Girls in Science, Optimum is celebrating the amazing women we work with by asking them to nominate their favourite scientific advancement or innovation. The answers are broad and varying and make for an uplifting read – learn what inspired the amazing women we work with to pursue […]
